Ascorbic Acid for Interference Testing

Ascorbic Acid for Interference Testing_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

Catalog number:	K2010001A
Lot number:	Batch Dependent
Expiration date:	Batch Dependent
Volume:	1 mL
Appearance:	Clear Solution
Concentration:	176 mg/mL (1.0 M) in diluent A (provided)
Molar Mass	176.12 g/mol
Storage:	At -20°C or lower. Avoid repeated freeze-thaw cycles. Aliquot as needed.
Other names:	Ascorbate, L-ascrobate, L-ascorbic acid

_x000D_

All Interference Products Brochure_x000D_

_x000D_ _x000D_ _x000D_ References_x000D_

_x000D_
• Schiettecatte, J., Anckaert, E., and Smitz, J. (2012). Interferences in Immunoassays. Advances in Immunoassay Technology.
_x000D_
• Miller, J. J., and Levinson, S. S. (1996). Interferences In Immunoassays. Immunoassay, 165‚Äì190.
_x000D_
• Ward, G. (2013). Rational investigations of immunoassay interferences. Pathology, 45.
_x000D_
• Park, J. Y., and Kricka, L. J. (2013). Interferences in Immunoassay. The Immunoassay Handbook, 403‚Äì416.
_x000D_
• EP07: Interference Testing in Clinical Chemistry. (2020). Retrieved from https://clsi.org/standards/products/method-evaluation/documents/ep07/.
_x000D_
• Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
_x000D_
• Coussens NP, Auld D, Roby P, Walsh J, Baell JB, Kales S, Hadian K, Dahlin JL. Compound-Mediated Assay Interferences in Homogenous Proximity Assays. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-._x000D_ 2020 Feb 1.
_x000D_
• Wang L, Zhang J, An X, Duan H. Recent progress on the organic and metal complex-based fluorescent probes for monitoring nitric oxide in living biological systems. Org Biomol Chem. 2020 Feb 26;18(8):1522-1549.
_x000D_
• Kawasaki H, Suzuki T, Ito K, Takahara T, Goto-Inoue N, Setou M, Sakata K, Ishida N. Minos-insertion mutant of the Drosophila GBA gene homologue showed abnormal phenotypes of climbing ability, sleep and life span with accumulation of hydroxy-glucocerebroside. Gene. 2017 May 30;614:49-55.
_x000D_
• Hull B. Aberrantly elevated TSH level due to human anti-mouse antibodies (HAMA) interference with thyrotropin assay. J S C Med Assoc. 2012 Feb;108(1):12-3.
_x000D_
• Degn SE, Andersen SH, Jensen L, Thiel S, Jensenius JC. Assay interference caused by antibodies reacting with rat kappa light-chain in human sera. J Immunol Methods. 2011 Sep 30;372(1-2):204-8.
_x000D_

_x000D_ Products Related to Ascorbic Acid_x000D_ _x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-extra-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-kit/_x000D_ _x000D_ https://moleculardepot.com/product/hama-interference-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-human-plasma/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-diluent/

Catalog #: K2010001A

0.15

2

0.5